Literature DB >> 6833624

Antipyretic therapy with diclofenac sodium. Observations on effect and serious side effects in critically ill patients.

D F Zandstra, C P Stoutenbeek, J P Alexander.   

Abstract

The antipyretic activity of diclofenac sodium, 100 mg suppository was studied retrospectively in 21 applications in seven intensive care patients. Diclofenac sodium proved to be a very potent antipyretic agent with serious side effects. Acute oliguria and protracted circulatory shock occurred after administration, necessitating the administration of increasing amounts of dopamine and i.v. fluids. Possible mechanisms involved are discussed.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6833624     DOI： 10.1007/bf01693701

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


  8 in total

1.  Cardiovascular and other effects of prostaglandins E 2 and F 2 in man.

Authors:  S M Karim; K Somers; K Hillier
Journal:  Cardiovasc Res       Date:  1971-07       Impact factor: 10.787

Review 2.  Prostaglandins, renal function and vascular regulation.

Authors:  R Horton; R Zipser; M Fichman
Journal:  Med Clin North Am       Date:  1981-07       Impact factor: 5.456

3.  Pharmacological properties of diclofenac sodium and its metabolites.

Authors:  R Menassé; P R Hedwall; J Kraetz; C Pericin; L Riesterer; A Sallmann; R Ziel; R Jaques
Journal:  Scand J Rheumatol Suppl       Date:  1978

4.  Renal response to vasopressin after inhibition of prostaglandin synthesis.

Authors:  G Fejes-Tóth; A Magyar; J Walter
Journal:  Am J Physiol       Date:  1977-05

5.  The effect of indomethacin on kidney function and plasma renin activity in man.

Authors:  A J Donker; L Arisz; J R Brentjens; G K van der Hem; H J Hollemans
Journal:  Nephron       Date:  1976       Impact factor: 2.847

6.  Coronary vasoconstrictor effect of indomethacin in patients with coronary-artery disease.

Authors:  P L Friedman; E J Brown; S Gunther; R W Alexander; W H Barry; G H Mudge; W Grossman
Journal:  N Engl J Med       Date:  1981-11-12       Impact factor: 91.245

7.  Acute oliguric renal failure induced by indomethacin: possible mechanism.

Authors:  J J Walshe; R C Venuto
Journal:  Ann Intern Med       Date:  1979-07       Impact factor: 25.391

8.  Effects of prostaglandins E2, I2 and F2 alpha, arachidonic acid and indomethacin on pressor responses to norepinephrine in conscious rats.

Authors:  T Okuno; K Kondo; H Suzuki; T Saruta
Journal:  Prostaglandins       Date:  1980-06
  8 in total
  8 in total

1.  Antipyretic therapy in intensive care.

Authors:  D F Zandstra; C P Stoutenbeek
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

Review 2.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

Review 3.  The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients.

Authors:  A Bodenham; M P Shelly; G R Park
Journal:  Clin Pharmacokinet       Date:  1988-06       Impact factor: 6.447

Review 4.  Pharmacokinetics of common analgesics, anti-inflammatories and antipyretics in children.

Authors:  P D Walson; M E Mortensen
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

5.  Antipyretic therapy in ICU patients: evaluation of low dose diclofenac sodium.

Authors:  A Pesenti; A Riboni; E Basilico; E Grossi
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

6.  Continuous low dose diclofenac sodium infusion to control fever in neurosurgical critical care.

Authors:  Manuela Cormio; Giuseppe Citerio
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

Review 7.  Continuous intravenous low-dose diclofenac sodium to control a central fever after ischemic stroke in the intensive care unit: a case report and review of the literature.

Authors:  L G Giaccari; M C Pace; M B Passavanti; P Sansone; V Esposito; C Aurilio; V Pota
Journal:  J Med Case Rep       Date:  2019-12-18

8.  Parenteral diclofenac infusion significantly decreases brain-tissue oxygen tension in patients with poor-grade aneurysmal subarachnoid hemorrhage.

Authors:  Alois J Schiefecker; Bettina Pfausler; Ronny Beer; Florian Sohm; Jan Sabo; Viktoria Knauseder; Marlene Fischer; Anelia Dietmann; Werner O Hackl; Claudius Thomé; Erich Schmutzhard; Raimund Helbok
Journal:  Crit Care       Date:  2013-05-12       Impact factor: 9.097
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.